Kyverna Therapeutics, Inc.KYTXNASDAQ
Loading
Net Income Growth AcceleratingAccelerating
Percentile Rank50
Studio
Year-over-Year Change

Year-over-year net income growth rate

Latest
-26.54%
↑ 48% vs avg
Percentile
P50
Within normal range
Streak
1 yr
Consecutive growthAccelerating
Average
-51.26%
Historical baseline
PeriodValue
2025-26.54%
2024-111.17%
2023-108.93%
2022-9.65%
20210.00%